Company & Sponsor Intelligence
Insel Gruppe AG, University Hospital Bern
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting1
Completed1
Countries1
Therapeutic footprint
adhdautismunclassified
Indexed studies
NCT06892457PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
epilepsy · SwitzerlandRECRUITING
epilepsy · SwitzerlandRECRUITING
NCT07162831Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study
adhd · SwitzerlandNA
adhd · SwitzerlandNA
NCT04930471Steroid and Behaviour Changes Under Metformin
autism · SwitzerlandUNKNOWN
autism · SwitzerlandUNKNOWN
NCT04361760Signal Propagation and Its Relationship to Cognitive Performance in the Aging Human Brain (Focus or Spread)
unclassified · SwitzerlandNA
unclassified · SwitzerlandNA
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →